Stay updated on Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma
Sign up to get notified when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.

Latest updates to the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page
- CheckyesterdayChange DetectedA new revision entry labeled v3.5.5 has been added to the study’s record history, following the previous v3.5.4, indicating the record has been updated to a newer version.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new Revision: v3.5.4 entry has been added to the record history. The previous Revision: v3.5.3 entry has been removed.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedA new revision entry, v3.5.3, was added to the Record History, replacing the previous v3.5.2 as the latest version.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision history now includes a new entry for v3.5.2. The previous v3.5.0 entry has been removed.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision history now includes a new entry for v3.5.0 and removes the previous v3.4.3 entry.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision v3.4.3 appears in the history, replacing the previous v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.